Rocket Lab and Planet Labs Report Strong Financials Amid Space Economy Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy RKLB?
Source: NASDAQ.COM
- Rocket Lab Revenue Surge: Rocket Lab achieved $602 million in revenue for fiscal year 2025, marking a 38% year-over-year increase, which underscores the lucrative potential and ongoing growth of the space economy.
- Significant Backlog Growth: The company's backlog soared to $1.85 billion, reflecting a 73% year-over-year increase, indicating strong market demand for its services and confidence in future growth prospects.
- Planet Labs' Strong Performance: Planet Labs reported $306 million in revenue for fiscal year 2026, with its backlog growing 79% to $900 million, showcasing its commercial viability and wide-ranging applications in the Earth observation sector.
- Optimistic Space Economy Outlook: With SpaceX's IPO on the horizon, it is expected to catalyze the growth of the entire space economy, positioning companies like Rocket Lab and Planet Labs to benefit from heightened investor enthusiasm and potentially drive their stock prices higher.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RKLB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RKLB
Wall Street analysts forecast RKLB stock price to rise
11 Analyst Rating
7 Buy
4 Hold
0 Sell
Moderate Buy
Current: 82.290
Low
63.00
Averages
86.89
High
120.00
Current: 82.290
Low
63.00
Averages
86.89
High
120.00
About RKLB
Rocket Lab Corporation is an end-to-end space company. The Company designs and manufactures small and medium-class rockets, spacecraft and spacecraft components, and related software and services to support the space economy. The Company delivers reliable launch services, satellite manufacture, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions that make it easier to access space. Its Launch Services segment provides launch and launch-related services to customers on a dedicated mission or ride-share basis. Its Space Systems segment comprises the design and manufacture of spacecraft components and spacecraft program management services, space data applications, and mission operations. Its space systems solutions are the building blocks for spacecraft, which include composite structures, reaction wheels, star trackers, solar solutions, radios, separation systems, and command and control spacecraft software.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analyzing Rocket Lab's Market Prospects
- Market Opportunity: With increasing investments in satellite constellations by governments and companies, Rocket Lab (NASDAQ: RKLB) is positioned in a rapidly growing market, with projections estimating the market size to reach $1 trillion by 2025, indicating significant potential benefits for the company.
- Revenue Growth: In Q4 2023, Rocket Lab reported a 36% year-over-year revenue increase to $180 million, primarily driven by new launch contracts with government and commercial clients, showcasing its competitive edge in the aerospace sector.
- Profitability Challenges: Despite revenue progress, the company faces an operating loss of $51 million, largely due to rising R&D costs, highlighting significant hurdles that must be overcome before achieving profitability.
- Valuation Risks: With a market cap of $49 billion and a price-to-sales ratio of 79, significantly higher than the S&P 500's 3.5, Rocket Lab's stock price is under considerable downward pressure, necessitating careful evaluation of its future growth potential.
See More
ARK Investment Management Increases NTLA Holdings
- Consistent NTLA Accumulation: ARK Investment Management has steadily increased its holdings in Intellia Therapeutics (NTLA) throughout 2026, acquiring over 263,848 shares from January to April, with a potential investment exceeding $3.5 million, reflecting a strong long-term confidence in the biotech firm.
- Positive Clinical Trial Results: Intellia recently reported positive Phase 3 trial results for lonvoculin ziclumeran (lonvo-z) for hereditary angioedema treatment and has initiated a rolling Biologics License Application submission to the FDA, aiming for a potential U.S. launch in the first half of 2027.
- Rocket Lab Stock Sale: ARK's second sale of Rocket Lab (RKLB) stock this month involved offloading 50,312 shares, potentially worth over $4 million, indicating a strategy to lock in gains after RKLB's impressive 262% rise over the past year.
- Retail Investor Sentiment: On Stocktwits, retail sentiment for NTLA is in the 'extremely bullish' territory, while RKLB is 'bullish', suggesting positive market expectations for both stocks, despite ARKK and ARKQ showing 'bearish' sentiment.
See More
Jim Cramer's Insights on Various Stocks
- Joby Aviation Risk Assessment: Joby Aviation is deemed too risky, with analysts advising new investors to be cautious to avoid disappointment from potential stock price drops, which could hinder its ability to attract new investors.
- BillionToOne Potential: Despite the overall poor performance of diagnostic companies, BillionToOne is viewed as a potential winner, with analysts believing its future performance is promising, which may draw more investor interest in its stock.
- Boston Scientific Competitive Pressure: Boston Scientific faces intense competition, with analysts noting that its market position is under threat; however, there is still potential for a rebound, prompting investors to watch for a price bottom before deciding to buy.
- Rocket Lab Investment Opportunity: Rocket Lab is considered a speculative stock worth investing in, with analysts optimistic about its future performance, especially leading up to the SpaceX IPO, which could attract more speculative investments.
See More
Rocket Lab's Long-Term Investment Outlook
- Market Potential: According to McKinsey, the space market is expected to reach $1 trillion by 2025, while Rocket Lab's market cap stands at only $49 billion, indicating significant growth potential in the rapidly expanding space industry.
- Significant Revenue Growth: Rocket Lab's Q4 revenue surged 36% year-over-year to $180 million, primarily driven by new launch contracts with government and commercial clients, showcasing its competitive edge in the aerospace market.
- Profitability Challenges: Despite revenue growth, the company reported operating losses of $51 million, although this represents a decrease from the previous year, indicating that investments in the development of the new Neutron rocket platform are starting to pay off.
- Valuation Risks: With a price-to-sales ratio of 79, significantly higher than the S&P 500's 3.5, Rocket Lab's stock price carries substantial risk, necessitating successful launches of its new rocket to achieve profitability and growth in the future.
See More
Four Stocks to Sell or Take Profits Before Earnings Reports
- Sell Recommendations: The video discusses four stocks suggested for selling or taking profits before their earnings reports, indicating a cautious market sentiment regarding their future performance.
- Market Dynamics: As of the trading day on April 24, 2026, the price fluctuations of these stocks may influence investor decisions, particularly in the sensitive period leading up to earnings announcements.
- Investment Strategy: The advice for investors to act before earnings reports may be aimed at locking in profits or avoiding potential declines, showcasing a keen insight into market trends.
- Video Content: The video provides insights on how to select stocks for selling, encouraging viewers to stay attuned to market changes and consider subscribing for more investment advice.
See More
Top Stocks to Buy if Market Drops Again
- Market Strategy: In a video published on April 17, 2026, analysts recommended five stocks as potential buys if the market drops again, aiming to help investors seize opportunities in uncertain market conditions.
- Return Potential: The video highlighted past recommendations like Netflix and Nvidia, which yielded returns of 498,522% and 1,276,807% respectively, underscoring the importance of selecting quality stocks for high potential gains.
- Community Advantage: By joining The Motley Fool's Stock Advisor, investors can access the latest top 10 stock recommendations, leveraging collective wisdom to enhance investment decisions and improve market performance.
- Transparency and Trust: Neil Rozenbaum disclosed his holdings, including AMD and Meta Platforms, which enhances the transparency of the information and helps viewers better understand the context and potential benefits of the recommendations.
See More
Analyzing Rocket Lab's Market Prospects
- Market Opportunity: With increasing investments in satellite constellations by governments and companies, Rocket Lab (NASDAQ: RKLB) is positioned in a rapidly growing market, with projections estimating the market size to reach $1 trillion by 2025, indicating significant potential benefits for the company.
- Revenue Growth: In Q4 2023, Rocket Lab reported a 36% year-over-year revenue increase to $180 million, primarily driven by new launch contracts with government and commercial clients, showcasing its competitive edge in the aerospace sector.
- Profitability Challenges: Despite revenue progress, the company faces an operating loss of $51 million, largely due to rising R&D costs, highlighting significant hurdles that must be overcome before achieving profitability.
- Valuation Risks: With a market cap of $49 billion and a price-to-sales ratio of 79, significantly higher than the S&P 500's 3.5, Rocket Lab's stock price is under considerable downward pressure, necessitating careful evaluation of its future growth potential.
See More
ARK Investment Management Increases NTLA Holdings
- Consistent NTLA Accumulation: ARK Investment Management has steadily increased its holdings in Intellia Therapeutics (NTLA) throughout 2026, acquiring over 263,848 shares from January to April, with a potential investment exceeding $3.5 million, reflecting a strong long-term confidence in the biotech firm.
- Positive Clinical Trial Results: Intellia recently reported positive Phase 3 trial results for lonvoculin ziclumeran (lonvo-z) for hereditary angioedema treatment and has initiated a rolling Biologics License Application submission to the FDA, aiming for a potential U.S. launch in the first half of 2027.
- Rocket Lab Stock Sale: ARK's second sale of Rocket Lab (RKLB) stock this month involved offloading 50,312 shares, potentially worth over $4 million, indicating a strategy to lock in gains after RKLB's impressive 262% rise over the past year.
- Retail Investor Sentiment: On Stocktwits, retail sentiment for NTLA is in the 'extremely bullish' territory, while RKLB is 'bullish', suggesting positive market expectations for both stocks, despite ARKK and ARKQ showing 'bearish' sentiment.
See More
Jim Cramer's Insights on Various Stocks
- Joby Aviation Risk Assessment: Joby Aviation is deemed too risky, with analysts advising new investors to be cautious to avoid disappointment from potential stock price drops, which could hinder its ability to attract new investors.
- BillionToOne Potential: Despite the overall poor performance of diagnostic companies, BillionToOne is viewed as a potential winner, with analysts believing its future performance is promising, which may draw more investor interest in its stock.
- Boston Scientific Competitive Pressure: Boston Scientific faces intense competition, with analysts noting that its market position is under threat; however, there is still potential for a rebound, prompting investors to watch for a price bottom before deciding to buy.
- Rocket Lab Investment Opportunity: Rocket Lab is considered a speculative stock worth investing in, with analysts optimistic about its future performance, especially leading up to the SpaceX IPO, which could attract more speculative investments.
See More
Rocket Lab's Long-Term Investment Outlook
- Market Potential: According to McKinsey, the space market is expected to reach $1 trillion by 2025, while Rocket Lab's market cap stands at only $49 billion, indicating significant growth potential in the rapidly expanding space industry.
- Significant Revenue Growth: Rocket Lab's Q4 revenue surged 36% year-over-year to $180 million, primarily driven by new launch contracts with government and commercial clients, showcasing its competitive edge in the aerospace market.
- Profitability Challenges: Despite revenue growth, the company reported operating losses of $51 million, although this represents a decrease from the previous year, indicating that investments in the development of the new Neutron rocket platform are starting to pay off.
- Valuation Risks: With a price-to-sales ratio of 79, significantly higher than the S&P 500's 3.5, Rocket Lab's stock price carries substantial risk, necessitating successful launches of its new rocket to achieve profitability and growth in the future.
See More
Four Stocks to Sell or Take Profits Before Earnings Reports
- Sell Recommendations: The video discusses four stocks suggested for selling or taking profits before their earnings reports, indicating a cautious market sentiment regarding their future performance.
- Market Dynamics: As of the trading day on April 24, 2026, the price fluctuations of these stocks may influence investor decisions, particularly in the sensitive period leading up to earnings announcements.
- Investment Strategy: The advice for investors to act before earnings reports may be aimed at locking in profits or avoiding potential declines, showcasing a keen insight into market trends.
- Video Content: The video provides insights on how to select stocks for selling, encouraging viewers to stay attuned to market changes and consider subscribing for more investment advice.
See More
Top Stocks to Buy if Market Drops Again
- Market Strategy: In a video published on April 17, 2026, analysts recommended five stocks as potential buys if the market drops again, aiming to help investors seize opportunities in uncertain market conditions.
- Return Potential: The video highlighted past recommendations like Netflix and Nvidia, which yielded returns of 498,522% and 1,276,807% respectively, underscoring the importance of selecting quality stocks for high potential gains.
- Community Advantage: By joining The Motley Fool's Stock Advisor, investors can access the latest top 10 stock recommendations, leveraging collective wisdom to enhance investment decisions and improve market performance.
- Transparency and Trust: Neil Rozenbaum disclosed his holdings, including AMD and Meta Platforms, which enhances the transparency of the information and helps viewers better understand the context and potential benefits of the recommendations.
See More
